Dabigatran and warfarin: comparative analysis of safety and cost.

被引：0
|
作者：
Vakil, Niyati H. [1 ]
Leber, Molly [1 ]
Bliss, Gina [1 ]
Yazdi, Marina [1 ]
机构：
[1] Yale New Haven Med Ctr, New Haven, CT 06504 USA
来源：
PHARMACOTHERAPY | 2012年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
6E
引用
收藏
页码：E179 / E179
页数：1
相关论文
共 50 条
  • [11] Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine care
    Gorst-Rasmussen, Anders
    Lip, Gregory Y. H.
    Larsen, Torben Bjerregaard
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 (11) : 1236 - 1244
  • [12] Safety and Effectiveness of Dabigatran Relative to Warfarin in Routine Care
    Seeger, John D.
    Bartels, Dorothee B.
    Huybrechts, Krista
    Bykov, Katsiaryna
    Shash, Dalia
    Zint, Kristina
    Schneeweiss, Sebastian
    CIRCULATION, 2014, 130
  • [13] Questions in the comparative effectiveness of dabigatran and warfarin in atrial fibrillation
    Alonso, Alvaro
    Lutsey, Pamela L.
    Chen, Lin Y.
    MacLehose, Richard F.
    Bengtson, Lindsay G. S.
    JOURNAL OF CARDIOLOGY, 2017, 70 (1-2) : 99 - 100
  • [14] Is dabigatran cost-effective compared with warfarin in patients with AF?
    Alexandra King
    Nature Reviews Cardiology, 2012, 9 (1) : 3 - 3
  • [15] Monitoring of Safety and Effectiveness of Dabigatran Relative to Warfarin in Routine Care
    Gopalakrishnan, Chandrasekar
    Huybrechts, Krista F.
    Ortiz, Adrian S.
    Zint, Kristina
    Bartels, Dorothee B.
    Schneeweiss, Sebastian
    CIRCULATION, 2017, 136
  • [16] Improve Warfarin Therapy or Use Dabigatran for Patients with Atrial Fibrillation - A Cost-Effectiveness Analysis
    You, Joyce H.
    Tsui, Kia K.
    Wong, Raymond S.
    Cheng, Gregory
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (09): : 1334 - 1334
  • [17] STROKE PROPHYLAXIS WITH WARFARIN AND DABIGATRAN FOR PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION - A COST ANALYSIS
    Ali, A. N.
    Bailey, C.
    Abdulhafiz, A. H.
    AGE AND AGEING, 2013, 42 : 31 - 31
  • [18] SENSITIVITY ANALYSIS OF UNIT GENERATED COST.
    Gupta, P.K.
    1600, (67): : 1 - 2
  • [19] ANALYSIS OF COST-EFFECTIVENESS OF WARFARIN VS. DABIGATRAN ETEXILATE IN ATRIAL FIBRILLATION IN ECUADOR
    Penaherrera, E.
    Tettamanti, D.
    Aguirre, F.
    Puyol, L. F.
    Cardenas, E.
    Torres, G.
    Herran, S.
    VALUE IN HEALTH, 2015, 18 (07) : A830 - A830
  • [20] A Multiperspective Analysis of the Influence of Medicare Part D on the Cost-effectiveness of Dabigatran versus Warfarin
    Salata, Brian M.
    Hutton, David W.
    Levine, Deborah A.
    Froehlich, James B.
    Barnes, Geoffrey D.
    CIRCULATION, 2014, 130
12345